Recordati Rare Diseases Canada inc. annonce le lancement de PANHEMATIN® au Canada
TORONTO--(BUSINESS WIRE)--Recordati Rare Diseases Canada Inc. today announced the commercial launch of PANHEMATIN®, for treatment of acute intermittent porphyria (AIP).